Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • After-school exercise program enhances cognition in 7-, 8- and 9-year-olds

  • Rising prevalence of sleep apnea in U.S. threatens public health

  • New clues revealed to understand brain stimulation

  • Selectively rewiring brain's circuitry to treat depression

  • New learning mechanism for individual nerve cells

  • Rising prevalence of sleep apnea in US threatens public health

  • Sleep twitches light up the brain

  • The dangers of teens using marijuana

  • Talk therapy -- not medication -- best for social anxiety disorder, large study finds

  • Signature of aging in brain: Researchers suggest that the brain's 'immunological age' is what counts

  •